Validating algorithms under CLIA and GLP requirements

Validating algorithms under CLIA and GLP requirements

Loading
Loading Social Plug-ins...
Save to myLibrary Post page as Slide Download PDF
Go to Page # Page of 52
Page(s): 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52

Description: Validating algorithms under CLIA and GLP requirements, Flagship Bio sciences, 3 kinds of people, Vendor validation gap with CLIA. US Food and Drug Administration, Medical Device Manufacturers Regulations, Digital Pathology FDA 510k Clearances Immunohistochemistry, Hematology and Pathology Devices Advisory Committee, CAP Anatomic Pathology Checklist* that applies to Digital Pathology, ASCO/CAP Guidelines IHC ER/PgR Breast [2010], Recommendations for validating estrogen.

 
Author: Steve Potts (Fellow) | Visits: 2587 | Page Views: 2803
Domain:  Medicine Category: Biotech/Pharma Subcategory: FDA Practice and Patent Law 
Upload Date:
Short URL: http://medical.wesrch.com/pdfME1XXFXMHKMET

Loading
Loading...



px *        px *

* Default width and height in pixels. Change it to your required dimensions.

 
Subscribe
x